Related Experiment Video
Updated: May 4, 2026
03:43
Laparoscopic Non-Mesh Cerclage Pectopexy for Pelvic Organ Prolapse
Published on: September 13, 2022
5.3K
How do we treat severely prolapsed true ectopia cordis?
Naoki Masaki1, Hideki Tatewaki1, Takehiko Sanada2
1Department of Cardiovascular Surgery, Miyagi Children's Hospital, Sendai, Japan.
Summary
Ectopia cordis, a rare heart malformation, was successfully treated in a complex case. The treatment involved intracardiac repair and delayed sternal closure, offering a new approach for this challenging condition.
Area of Science:
- Cardiovascular Surgery
- Congenital Malformations
- Pediatric Cardiology
Background:
- Ectopia cordis is a rare congenital anomaly with the heart located outside the chest.
- Treatment is complex, particularly with associated congenital heart disease and significant protrusion.
- Surgical outcomes for ectopia cordis remain challenging.
Observation:
- A case of ectopia cordis with congenital heart disease and severe protrusion is presented.
- The patient required a multi-stage surgical approach.
- Intracardiac repair and delayed sternal closure were key components of the treatment.
Findings:
- Successful intracardiac repair of the congenital heart defect was achieved.
- Delayed sternal closure using local skin flaps was performed.
- The combined approach led to a favorable outcome in this complex case.
Implications:
- This case demonstrates a viable strategy for managing complex ectopia cordis.
- The technique of delayed sternal closure may be applicable to similar challenging cases.
- Further research into optimal surgical timing and techniques for ectopia cordis is warranted.
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
535
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535
01:25Aortic Regurgitation III: Medical Management
598
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598
01:17Pericarditis III: Medical Management
586
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
586
01:30Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
01:29Cardiomyopathy V: Interprofessional Care
753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753